Is Compass Therapeutics, Inc. (CMPX) a Buy, Sell, or Hold?
Compass Therapeutics, Inc.
NASDAQ:CMPX
$2.19 USD
-$0.07 (-3.1%)
- Volume
- 2.01M
- Average Volume
- 8.15M
- Market Capitalization
- $302.85M
- P/E Ratio
- -5.15
- Dividend Yield
- 0.00%
- Price Target
- $11.00
- Year High
- $6.88
- Year Low
- $1.61
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $19.04
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
23
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
5
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 7.27M
CMPX Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
CMPX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Lerner Neil | officer: Chief Accounting Officer | 2026-04-29 | P-Purchase | 1.89 | 2026-04-30 |
| Anderman Jonathan | officer: General Counsel | 2026-04-29 | P-Purchase | 1.89 | 2026-04-30 |
| Anderman Jonathan | officer: General Counsel | 2026-04-29 | A-Award | 1.89 | 2026-04-29 |
| Lerner Neil | officer: Chief Accounting Officer | 2026-04-29 | A-Award | 1.89 | 2026-04-29 |
| Schuetz Thomas J. | director, officer: CHIEF EXECUTIVE OFFICER | 2026-02-08 | F-InKind | 6.52 | 2026-02-10 |
| Schuetz Thomas J. | director, officer: CHIEF EXECUTIVE OFFICER | 2026-01-09 | F-InKind | 5.35 | 2026-01-12 |
| Shin Barry | officer: CFO | 2026-01-02 | A-Award | 5.17 | 2026-01-05 |
| Shin Barry | officer: CFO | 2026-01-02 | A-Award | 5.17 | 2026-01-05 |
| Sirard Cynthia | officer: Chief Medical Officer | 2026-01-02 | A-Award | 5.17 | 2026-01-05 |
| Schuetz Thomas J. | director, officer: CEO | 2026-01-02 | A-Award | 5.17 | 2026-01-05 |
| Schuetz Thomas J. | director, officer: CEO | 2026-01-02 | A-Award | 5.17 | 2026-01-05 |
| Prasad Arjun | officer: Chief Commercial Officer | 2026-01-02 | A-Award | 5.17 | 2026-01-05 |
| LINDAHL RICHARD S | director | 2026-01-02 | A-Award | 5.17 | 2026-01-05 |
| Chiniara Ellen | director | 2026-01-02 | A-Award | 5.17 | 2026-01-05 |
| Lerner Neil | officer: Chief Accounting Officer | 2026-01-02 | A-Award | 5.17 | 2026-01-05 |
| Lerner Neil | officer: Chief Accounting Officer | 2026-01-02 | A-Award | 5.17 | 2026-01-05 |
| GRAY MARY ANN | director | 2026-01-02 | A-Award | 5.17 | 2026-01-05 |
| Boylan James P | director | 2026-01-02 | A-Award | 5.17 | 2026-01-05 |
| GORDON CARL L | director | 2026-01-02 | A-Award | 5.17 | 2026-01-05 |
| Ferneau Philip | director | 2026-01-02 | A-Award | 5.17 | 2026-01-05 |
| Anderman Jonathan | officer: General Counsel | 2026-01-02 | A-Award | 5.17 | 2026-01-05 |
| Anderman Jonathan | officer: General Counsel | 2026-01-02 | A-Award | 5.17 | 2026-01-05 |
| Sirard Cynthia | officer | 2026-01-02 | 0 | 2026-01-05 | |
| Prasad Arjun | officer | 2026-01-02 | 0 | 2026-01-05 | |
| Schuetz Thomas J. | director, officer: CHIEF EXECUTIVE OFFICER | 2025-11-16 | F-InKind | 4.83 | 2025-11-18 |
| Schuetz Thomas J. | director, officer: CHIEF EXECUTIVE OFFICER | 2025-05-27 | P-Purchase | 2.11 | 2025-05-27 |
| GORDON CARL L | director, 10 percent owner: | 2025-04-09 | S-Sale | 1.59 | 2025-04-11 |
| ORBIMED ADVISORS LLC | director, 10 percent owner: | 2025-04-09 | S-Sale | 1.59 | 2025-04-11 |
| Anderman Jonathan | officer: Gen Counsel & Corporate Sec | 2025-04-07 | P-Purchase | 1.54 | 2025-04-08 |
| Lerner Neil | officer: CHIEF ACCOUNTING OFFICER | 2025-04-07 | P-Purchase | 1.42 | 2025-04-08 |
| Shin Barry | officer: CFO | 2025-02-11 | A-Award | 3.65 | 2025-02-13 |
| Schuetz Thomas J. | director, officer: CHIEF EXECUTIVE OFFICER | 2025-02-11 | A-Award | 3.65 | 2025-02-13 |
| LINDAHL RICHARD S | director | 2025-02-11 | A-Award | 3.65 | 2025-02-13 |
| Lerner Neil | officer: SVP, CAO | 2025-02-11 | A-Award | 3.65 | 2025-02-13 |
| GRAY MARY ANN | director | 2025-02-11 | A-Award | 3.65 | 2025-02-13 |
| Ferneau Philip | director | 2025-02-11 | A-Award | 3.65 | 2025-02-13 |
| Chiniara Ellen | director | 2025-02-11 | A-Award | 3.65 | 2025-02-13 |
| Anderman Jonathan | officer: Sr VP, Gen Counsel & Corp Sec | 2025-02-11 | A-Award | 3.65 | 2025-02-13 |
| GORDON CARL L | director, 10 percent owner: | 2025-02-11 | A-Award | 3.65 | 2025-02-13 |
| Boylan James P | director | 2025-02-11 | A-Award | 3.65 | 2025-02-13 |
| Schuetz Thomas J. | director, officer: CEO | 2025-02-08 | F-InKind | 3.5 | 2025-02-11 |
| Schuetz Thomas J. | director, officer: CEO | 2025-01-09 | F-InKind | 1.86 | 2025-01-13 |
| Shin Barry | officer: CFO | 2024-12-09 | A-Award | 1.65 | 2024-12-10 |
| Shin Barry | officer: CFO | 2024-12-09 | A-Award | 1.65 | 2024-12-10 |
| Shin Barry | officer | 2024-12-09 | 0 | 2024-12-10 | |
| Lerner Neil | officer: VP Finance | 2024-12-09 | 0 | 2024-12-10 | |
| Lerner Neil | officer: VP Finance | 2024-12-09 | 2.4 | 2024-12-10 | |
| Lerner Neil | officer: VP Finance | 2024-12-09 | 5 | 2024-12-10 | |
| Lerner Neil | officer: VP Finance | 2024-12-09 | 1.2 | 2024-12-10 | |
| Lerner Neil | officer: VP Finance | 2024-12-09 | 3.83 | 2024-12-10 | |
| Lerner Neil | officer: VP Finance | 2024-12-09 | 3.93 | 2024-12-10 | |
| Lerner Neil | officer: VP Finance | 2024-12-09 | 3.5 | 2024-12-10 | |
| Lerner Neil | officer: VP Finance | 2024-12-09 | 1.57 | 2024-12-10 | |
| Anderman Jonathan | officer: Sr VP, Gen Counsel & Corp Sec | 2024-08-13 | A-Award | 1.2 | 2024-08-14 |
| Anderman Jonathan | officer: Sr VP, Gen Counsel & Corp Sec | 2024-08-01 | 0 | 2024-08-09 | |
| Anderman Jonathan | officer: Sr VP, Gen Counsel & Corp Sec | 2024-08-01 | 1.57 | 2024-08-09 | |
| Anderman Jonathan | officer: Sr VP, Gen Counsel & Corp Sec | 2024-08-01 | 4.05 | 2024-08-09 | |
| Anderman Jonathan | officer: Sr VP, Gen Counsel & Corp Sec | 2024-08-01 | 3.93 | 2024-08-09 | |
| Anderman Jonathan | officer: Sr VP, Gen Counsel & Corp Sec | 2024-08-01 | 3.83 | 2024-08-09 | |
| Anderman Jonathan | officer: Sr VP, Gen Counsel & Corp Sec | 2024-08-01 | 2.4 | 2024-08-09 | |
| Boylan James P | director | 2024-03-08 | A-Award | 1.96 | 2024-03-11 |
| GRAY MARY ANN | director | 2024-02-09 | A-Award | 1.57 | 2024-02-14 |
| LINDAHL RICHARD S | director | 2024-02-09 | A-Award | 1.57 | 2024-02-14 |
| GORDON CARL L | director, 10 percent owner: | 2024-02-09 | A-Award | 1.57 | 2024-02-14 |
| Chiniara Ellen | director | 2024-02-09 | A-Award | 1.57 | 2024-02-14 |
| Ferneau Philip | director | 2024-02-09 | A-Award | 1.57 | 2024-02-14 |
| Bisker-Leib Vered | director, officer: CHIEF EXECUTIVE OFFICER | 2024-02-08 | F-InKind | 1.45 | 2024-02-09 |
| Schuetz Thomas J. | director, officer: PRESIDENT | 2024-02-08 | F-InKind | 1.45 | 2024-02-09 |
| Bisker-Leib Vered | director, officer: Chief Executive Officer | 2024-01-09 | A-Award | 1.93 | 2024-01-10 |
| Bisker-Leib Vered | director, officer: Chief Executive Officer | 2024-01-09 | A-Award | 1.93 | 2024-01-10 |
| Schuetz Thomas J. | director, officer: President of R&D | 2024-01-09 | A-Award | 1.93 | 2024-01-10 |
| Schuetz Thomas J. | director, officer: President of R&D | 2024-01-09 | A-Award | 1.93 | 2024-01-10 |
| Bisker-Leib Vered | officer: Chief Operating Officer | 2023-11-17 | F-InKind | 1.5 | 2023-11-21 |
| Schuetz Thomas J. | director, officer: CHIEF EXECUTIVE OFFICER | 2023-11-17 | F-InKind | 1.5 | 2023-11-21 |
| LINDAHL RICHARD S | director | 2023-04-21 | A-Award | 2.91 | 2023-04-24 |
| LINDAHL RICHARD S | director: | 2023-04-21 | 0 | 2023-04-24 | |
| Schuetz Thomas J. | director, officer: CHIEF EXECUTIVE OFFICER | 2023-03-10 | P-Purchase | 3.37 | 2023-03-10 |
| Schuetz Thomas J. | director, officer: CHIEF EXECUTIVE OFFICER | 2023-02-27 | P-Purchase | 3.98 | 2023-02-27 |
| Schuetz Thomas J. | director, officer: CHIEF EXECUTIVE OFFICER | 2023-02-15 | P-Purchase | 3.86 | 2023-02-15 |
| WURZER DAVID M | director | 2023-02-08 | A-Award | 3.93 | 2023-02-10 |
| WURZER DAVID M | director: | 2023-02-08 | 0 | 2023-02-10 | |
| Chiniara Ellen | director | 2023-02-08 | A-Award | 3.93 | 2023-02-09 |
| GRAY MARY ANN | director | 2023-02-08 | A-Award | 3.93 | 2023-02-09 |
| GORDON CARL L | director, 10 percent owner: | 2023-02-08 | A-Award | 3.93 | 2023-02-09 |
| Ferneau Philip | director | 2023-02-08 | A-Award | 3.93 | 2023-02-09 |
| Schuetz Thomas J. | director, officer: CHIEF EXECUTIVE OFFICER | 2023-02-08 | A-Award | 0 | 2023-02-09 |
| Schuetz Thomas J. | director, officer: CHIEF EXECUTIVE OFFICER | 2023-02-08 | A-Award | 3.93 | 2023-02-09 |
| Bisker-Leib Vered | officer: Chief Operating Officer | 2023-02-08 | A-Award | 0 | 2023-02-09 |
| Bisker-Leib Vered | officer: Chief Operating Officer | 2023-02-08 | A-Award | 3.93 | 2023-02-09 |
| Schuetz Thomas J. | officer: CHIEF EXECUTIVE OFFICER | 2023-01-31 | P-Purchase | 4.05 | 2023-01-31 |
| Schuetz Thomas J. | officer: CHIEF EXECUTIVE OFFICER | 2023-01-24 | P-Purchase | 4.19 | 2023-01-24 |
| Bisker-Leib Vered | officer: Chief Operating Officer | 2022-11-22 | S-Sale | 4.19 | 2022-11-25 |
| Bisker-Leib Vered | officer: Chief Operating Officer | 2022-11-23 | S-Sale | 4.3 | 2022-11-25 |
| Bisker-Leib Vered | officer: Chief Operating Officer | 2022-11-25 | S-Sale | 4.36 | 2022-11-25 |
| Boylan James P | None | 2022-11-04 | None | 2022-11-10 | |
| Boylan James P | director: | 2022-11-04 | 0 | 2022-11-10 | |
| ORBIMED ADVISORS LLC | director | 2022-11-08 | P-Purchase | 3.21 | 2022-11-10 |
| GORDON CARL L | director | 2022-11-08 | P-Purchase | 3.21 | 2022-11-10 |
| Schuetz Thomas J. | officer: CHIEF EXECUTIVE OFFICER | 2022-09-07 | P-Purchase | 3.03 | 2022-09-08 |
| Schuetz Thomas J. | officer: CHIEF EXECUTIVE OFFICER | 2022-09-01 | P-Purchase | 2.83 | 2022-09-01 |